undamentalytics Newsletter
Sign in

Phreesia, Inc. revenue

Phreesia, Inc.'s revenue was $481m in fiscal 2026, up 14.5% on the year before. Since fiscal 2018 ($79.8m) it has grown at a compound 25.2% a year. Over the last twelve months it was $508m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Jan 20182019Jan 20192020Jan 20202021Jan 20212022Jan 20222023Jan 20232024Jan 20242025Jan 20252026Jan 2026LTMJul 2026
Revenue80100125149213281356420481508
Growth on the year before—+25.1%+24.9%+19.1%+43.4%+31.7%+26.8%+17.8%+14.5%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to January 31, 2026
Products and services
Line of business Revenue Share YoY
Subscription and Services $219M 45.7% ▲ 11.7%
Network Solutions $140M 29.1% ▲ 14.9%
Payment Solutions $121M 25.3% ▲ 19.4%

From Phreesia, Inc.'s 10-K filed March 31, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Technology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Phreesia, Inc. $508m 12.9% 16.7%
Genedx Holdings Corp. $454m 25.4% 24.3%
Doximity, Inc. $656m 11.2% 14.5%
Goodrx Holdings, Inc. $785m -1.8% 1.8%
Healthstream Inc $321m 8.8% 5.4%
Health Catalyst, Inc. $292m -7.5% 0.9%

Compare with peers

Head to head: PHR vs WGSDOCS vs PHRGDRX vs PHR

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Phreesia, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Phreesia, Inc.